Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications
In recent years, nanomaterials have been used in the medical-dental field as new alternative antimicrobial agents. Bismuth subsalicylate (BSS) has been used as an antimicrobial agent, but the effect of BSS in the form of nanoparticles (BSS-nano) as a potential antimicrobial agent has not been tested, in specific against bacteria responsible for periodontal disease. The aim of this study was to evaluate the antibacterial effect of BSS-nano against oral anaerobic bacteria and to assess the safety of BSS-nano by evaluating their cytotoxicity in human gingival fibroblast (HGF-1) cells. BSS-nano were synthesized by laser ablation and were previously physico-chemically characterized using in vitro assays. The antibacterial activity was measured using the tetrazolium-based XTT assay, and cytotoxicity was determined using lactate dehydrogenase (LDH) and MTS assays in HGF-1 cells. Transmission electron microscopy of HGF-1 exposed to BSS-nano was also performed. BSS-nano was shown to have a primary size of 4-22 nm and a polygonal shape. Among the tested bacterial strains, those with a greater sensitivity to BSS-nano (highest concentration of 21.7 μg ml-1) were A. actinomycetemcomitans, C. gingivalis, and P. gingivalis. BSS-nano at a concentration of 60 μg ml-1 showed low cytotoxicity (6%) in HFG-1 cells and was mainly localized intracellularly in acidic vesicles. Our results indicate that the concentration of BSS-nano used as an effective antibacterial agent does not induce cytotoxicity in mammalian cells; thus, BSS-nano can be applied as an antibacterial agent in dental materials or antiseptic solutions.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
---|---|
Enthalten in: |
Nanotechnology - 28(2017), 43 vom: 27. Okt., Seite 435101 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vega-Jiménez, A L [VerfasserIn] |
---|
Links: |
---|
Themen: |
62TEY51RR1 |
---|
Anmerkungen: |
Date Completed 30.10.2018 Date Revised 30.10.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1088/1361-6528/aa8838 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM275098958 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM275098958 | ||
003 | DE-627 | ||
005 | 20231225004922.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1088/1361-6528/aa8838 |2 doi | |
028 | 5 | 2 | |a pubmed24n0917.xml |
035 | |a (DE-627)NLM275098958 | ||
035 | |a (NLM)28837052 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vega-Jiménez, A L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bismuth subsalicylate nanoparticles with anaerobic antibacterial activity for dental applications |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 30.10.2018 | ||
500 | |a Date Revised 30.10.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a In recent years, nanomaterials have been used in the medical-dental field as new alternative antimicrobial agents. Bismuth subsalicylate (BSS) has been used as an antimicrobial agent, but the effect of BSS in the form of nanoparticles (BSS-nano) as a potential antimicrobial agent has not been tested, in specific against bacteria responsible for periodontal disease. The aim of this study was to evaluate the antibacterial effect of BSS-nano against oral anaerobic bacteria and to assess the safety of BSS-nano by evaluating their cytotoxicity in human gingival fibroblast (HGF-1) cells. BSS-nano were synthesized by laser ablation and were previously physico-chemically characterized using in vitro assays. The antibacterial activity was measured using the tetrazolium-based XTT assay, and cytotoxicity was determined using lactate dehydrogenase (LDH) and MTS assays in HGF-1 cells. Transmission electron microscopy of HGF-1 exposed to BSS-nano was also performed. BSS-nano was shown to have a primary size of 4-22 nm and a polygonal shape. Among the tested bacterial strains, those with a greater sensitivity to BSS-nano (highest concentration of 21.7 μg ml-1) were A. actinomycetemcomitans, C. gingivalis, and P. gingivalis. BSS-nano at a concentration of 60 μg ml-1 showed low cytotoxicity (6%) in HFG-1 cells and was mainly localized intracellularly in acidic vesicles. Our results indicate that the concentration of BSS-nano used as an effective antibacterial agent does not induce cytotoxicity in mammalian cells; thus, BSS-nano can be applied as an antibacterial agent in dental materials or antiseptic solutions | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Organometallic Compounds |2 NLM | |
650 | 7 | |a Salicylates |2 NLM | |
650 | 7 | |a bismuth subsalicylate |2 NLM | |
650 | 7 | |a 62TEY51RR1 |2 NLM | |
650 | 7 | |a L-Lactate Dehydrogenase |2 NLM | |
650 | 7 | |a EC 1.1.1.27 |2 NLM | |
650 | 7 | |a Bismuth |2 NLM | |
650 | 7 | |a U015TT5I8H |2 NLM | |
700 | 1 | |a Almaguer-Flores, A |e verfasserin |4 aut | |
700 | 1 | |a Flores-Castañeda, M |e verfasserin |4 aut | |
700 | 1 | |a Camps, E |e verfasserin |4 aut | |
700 | 1 | |a Uribe-Ramírez, M |e verfasserin |4 aut | |
700 | 1 | |a Aztatzi-Aguilar, O G |e verfasserin |4 aut | |
700 | 1 | |a De Vizcaya-Ruiz, A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanotechnology |d 2003 |g 28(2017), 43 vom: 27. Okt., Seite 435101 |w (DE-627)NLM160620376 |x 1361-6528 |7 nnns |
773 | 1 | 8 | |g volume:28 |g year:2017 |g number:43 |g day:27 |g month:10 |g pages:435101 |
856 | 4 | 0 | |u http://dx.doi.org/10.1088/1361-6528/aa8838 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 28 |j 2017 |e 43 |b 27 |c 10 |h 435101 |